Secondary Prevention of Cancer-Associated Ischaemic Strokes

Abstract

Rodrick Babakhanlou, Monica K Wattana and Kumar Alagappan

Cancer patients face a higher risk of developing ischemic strokes in comparison to the general population. Ischaemic strokes in cancer patients either arise from cancer-associated hypercoagulability or as a result of treatment modalities for cancer and have a higher prevalence of presenting as diffuse and multifocal infarcts affecting different areas of the brain. Although Aspirin has been used for prevention of ischemic strokes or transient ischemic attacks in the non-cancerous population, there is no clear guidance for its use in the cancer population.

PDF